Identification of Objective Metabolomics-based Biomarkers of Yogurt Consumption
YOGBIO
1 other identifier
interventional
16
1 country
1
Brief Summary
Substantial evidence links yogurt consumption to a lower risk of type 2 diabetes (T2D). However, the existing evidence is derived exclusively from prospective cohort studies relying on self-reported dietary questionnaires, which-despite being validated-are subject to random and systematic errors that may compromise evidence quality and hinder regulatory approval. The project aims to discover and validate biomarkers of yogurt intake. The investigators will conduct a randomized, crossover, dose-response feeding trial involving 16 generally healthy adult participants (8 females, 8 males). The trial will include four 7-day diet periods, each separated by a 1-week washout. All diets will be based on a dairy-free background and supplemented with one of the following: (a) 1 serving of soy-based pudding (no yogurt), (b) 0.5 serving of yogurt, (c) 1 serving of yogurt, or (d) 2 servings of yogurt per 2,380 kcal/day. On the 7th day of each diet, participants will complete a mixed-meal test at INAF, consuming a smoothie containing the same yogurt dose as during the preceding days. Plasma samples collected in the postprandial state will be used to profile over 20,000 metabolites. Using artificial intelligence-based approaches, potential biomarkers of yogurt intake will be identified. These candidates will then be filtered using standard statistical methods to assess dose- and time-responsiveness, robustness, and biological plausibility. Biomarkers that meet all criteria will be considered validated indicators of yogurt intake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 19, 2026
CompletedStudy Start
First participant enrolled
March 23, 2026
CompletedFirst Posted
Study publicly available on registry
March 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
April 2, 2026
March 1, 2026
3 months
March 19, 2026
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biomarker of yogurt intake
The trial is specifically designed to discover an validate biomarkers of yogurt intake. All plasma samples collected on day 7, before and during the test meal challenge will be used for data analysis to conduct discovery and validaiton of yogurt biomarkers.
Day 7
Study Arms (4)
125 g per 2,380 kcal per day of a soy-based pudding (i.e., yogurt-free diet);
PLACEBO COMPARATORThe trial will consist of 4 predetermined diets, each lasting 7 days and separated by a 1-week washout period. The 4 diets will be based on a dairy-free background diet reflecting high adherence to Canada's food guide. In the yogurt-free control diet, the diet will include 125 g per 2,380 kcal per day of a soy-based pudding.
90 g per 2,380 kcal per day of yogurt (0.5 reference serving of yogurt per 2,380 kcal per day)
EXPERIMENTALThe trial will consist of 4 predetermined diets, each lasting 7 days and separated by a 1-week washout period. The 4 diets will be based on a dairy-free background diet reflecting high adherence to Canada's food guide. In the low yogurt-diet, the diet will include 90 g per 2,380 kcal per day of yogurt (i.e., 0.5 reference serving of yogurt per 2,380 kcal per day).
175 g per 2,380 kcal per day of yogurt (1 reference serving of yogurt per 2,380 kcal per day)
EXPERIMENTALThe trial will consist of 4 predetermined diets, each lasting 7 days and separated by a 1-week washout period. The 4 diets will be based on a dairy-free background diet reflecting high adherence to Canada's food guide. In the low yogurt-diet, the diet will include 175 g per 2,380 kcal per day of yogurt (1 reference serving of yogurt per 2,380 kcal per day).
350 g per 2,380 kcal per day of yogurt (2 reference servings per 2,380 kcal per day).
EXPERIMENTALThe trial will consist of 4 predetermined diets, each lasting 7 days and separated by a 1-week washout period. The 4 diets will be based on a dairy-free background diet reflecting high adherence to Canada's food guide. In the low yogurt-diet, the diet will include 350 g per 2,380 kcal per day of yogurt (2 reference servings per 2,380 kcal per day).
Interventions
During 6 days, participants will receive a fully-controlled dairy-free background diet reflecting high adherence to Canada's food guide. The diet will be complemented by 125 g per 2,380 kcal per day of a soy-based pudding. On day 7, participants will undergo an acute mixed-meal test to inform on time-responsiveness of the yogurt biomarkers. After a 12-hour fast, participants will arrive at INAF at 7:30 AM. The test meal will consist of a breakfast smoothie containing the same soy-based pudding provided daily during the preceding days. Plasma samples will be collected at baseline (fasting) and 1, 2, 4, and 6 hours post-meal.
During 6 days, participants will receive a fully-controlled dairy-free background diet reflecting high adherence to Canada's food guide. The diet will be complemented by 90 g per 2,380 kcal per day of yogurt (i.e., 0.5 reference serving of yogurt per 2,380 kcal per day). On day 7, participants will undergo an acute mixed-meal test to inform on time-responsiveness of the yogurt biomarkers. After a 12-hour fast, participants will arrive at INAF at 7:30 AM. The test meal will consist of a breakfast smoothie containing the same yogurt provided daily during the preceding days. Plasma samples will be collected at baseline (fasting) and 1, 2, 4, and 6 hours post-meal.
During 6 days, participants will receive a fully-controlled dairy-free background diet reflecting high adherence to Canada's food guide. The diet will be complemented by 175 g per 2,380 kcal per day of yogurt (i.e., 1 reference serving of yogurt per 2,380 kcal per day). On day 7, participants will undergo an acute mixed-meal test to inform on time-responsiveness of the yogurt biomarkers. After a 12-hour fast, participants will arrive at INAF at 7:30 AM. The test meal will consist of a breakfast smoothie containing the same yogurt provided daily during the preceding days. Plasma samples will be collected at baseline (fasting) and 1, 2, 4, and 6 hours post-meal.
During 6 days, participants will receive a fully-controlled dairy-free background diet reflecting high adherence to Canada's food guide. The diet will be complemented by 350 g per 2,380 kcal per day of yogurt (i.e., 2 reference servings per 2,380 kcal per day). On day 7, participants will undergo an acute mixed-meal test to inform on time-responsiveness of the yogurt biomarkers. After a 12-hour fast, participants will arrive at INAF at 7:30 AM. The test meal will consist of a breakfast smoothie containing the same yogurt provided daily during the preceding days. Plasma samples will be collected at baseline (fasting) and 1, 2, 4, and 6 hours post-meal.
Eligibility Criteria
You may qualify if:
- age: 18-70 years;
- BMI: 18-40 kg/m²;
- willingness to consume plain yogurt daily for 3 weeks;
- for coffee/tea consumers, willingness to consume these beverages without added milk, cream or sugar for 4 weeks.
You may not qualify if:
- lactose intolerance; blood donation within 2 months; severe chronic illness or ongoing treatment for conditions such as infections, autoimmune diseases, cancer, type 2 diabetes, Crohn's disease, celiac disease, hepatic or renal diseases;
- history of severe cancer, cardiovascular disease or bariatric surgery;
- unstable body weight for 3 months;
- illicit drug use or alcoholism; tobacco/cannabis smoking/vaping (ensuring no day-to-day fluctuations and objective reporting of consumption is too complex);
- allergies or aversions to components of the diets.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laval Universitylead
Study Sites (1)
Institute on nutrition and functional foods, Laval University
Québec, Quebec, G1V0A?, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Philippe Drouin-Chartier, PhD
Laval University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants and the CRC cannot be blinded to diet allocation. However, the exact amount of yogurt (or soy-based pudding) in the diets will not be disclosed to participants. The four diets will be randomly labeled with letters (e.g., A=high yogurt, B=soy, C=low yogurt, D=moderate yogurt). This approach will minimize information bias for the completion of the R24W at the end of each intervention. All analysis will be conducted by individuals blinded to the participants and the clinical research coordinator.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 19, 2026
First Posted
March 25, 2026
Study Start
March 23, 2026
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
April 2, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- When study will be completed and published.
- Access Criteria
- Access to the minimum dataset necessary to interpret, verify, and extend the research reported in this article will be made available upon request through a custom proprietary repository, in accordance with the conditions set by the local ethics review committee on data sharing. Data access requests should be directed to the principal investigator
Access to the minimum dataset necessary to interpret, verify, and extend the research reported in this article will be made available upon request through a custom proprietary repository, in accordance with the conditions set by the local ethics review committee on data sharing. Data access requests should be directed to the principal investigator